$1.5 B in New Healthcare Fundings

This week there was a significant amount of funding activity in the healthcare sector. Here's a breakdown by area:

• Drug Discovery & Development: Several companies developing drugs for various diseases received funding, including age-related diseases, cancer, Alzheimer's, tuberculosis, and malaria.
• Biotechnology: A number of biotech companies working on cell therapies, antibody treatments, and radiopharmaceuticals for different conditions secured funding.
• Digital Health: Companies providing telehealth services, mental health therapist support tools, and platforms for specific patient care (dementia, eating disorders) all raised money.
• Medical Devices & Diagnostics: Funding went to companies developing AI-powered medical coding, blood tests for Alzheimer's, and oral probiotics.
• Other: An out patient addiction treatment provider and a company creating an antidote for drink spiking also received funding.

Overall, this week's funding highlights continued investor interest in innovation across a broad spectrum of healthcare fields.

The top deals in terms of funding amount are:

1. Kailera Therapeutics ics: $400 million
2. Aktis Oncology logy: $175 million
3. Nusano : $115 million
4. Triveni Bio o: $115 million
5. Judo Bio : $100 million

See the full list here: https://twidh.substack.com/p/15-b-in-new-healthcare-fundings